Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Compared to the amniotic membrane, Wharton’s jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration

Fig. 5

PT and APTT of different cells and normal blood samples. Mean ± SD of five independent experiments performed in triplicate. * P > 0.05; ** P < 0.05; *** P < 0.001. APTT activated partial thromboplastin time, AM-MSCs amniotic membrane mesenchymal stem cells, HUVECs human umbilical vein endothelial cells, PT prothrombin time, WJ-MSCs Wharton’s jelly mesenchymal stem cells

Back to article page